Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherHighlighted Papers

Phosphoinositide 3-Kinase-δ,γ Inhibitor for Rheumatoid Arthritis

Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 216; DOI: https://doi.org/10.1124/jpet.114.0214HIb
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 348 no. 2 216
DOI 
https://doi.org/10.1124/jpet.114.0214HIb

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online January 15, 2014.

Copyright & Usage 
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

Statistics from Altmetric.com

Article usage

Article usage: January 2014 to October 2022

AbstractFullPdf
Jan 201412918
Feb 2014275
Mar 2014146
Apr 2014025
May 2014045
Jun 2014222
Jul 2014133
Aug 2014022
Sep 2014361
Oct 2014122
Nov 2014233
Dec 2014101
Jan 2015062
Feb 2015012
Mar 20150143
Apr 2015031
May 20150164
Jun 2015094
Jul 2015054
Aug 2015031
Sep 2015044
Oct 2015052
Nov 2015041
Dec 2015040
Jan 2016023
Feb 2016062
Mar 2016078
Apr 2016041
May 2016030
Jun 20160144
Jul 2016040
Aug 2016061
Sep 2016071
Oct 2016091
Nov 2016092
Dec 20160122
Jan 2017050
Feb 2017080
Mar 20170101
Apr 2017090
May 20170103
Jun 2017050
Jul 2017040
Aug 20170101
Sep 2017060
Oct 2017071
Nov 2017080
Dec 20170110
Jan 2018091
Feb 2018083
Mar 20180133
Apr 20180163
May 20180131
Jun 20180231
Jul 20180120
Aug 20180130
Sep 20180160
Oct 20180120
Nov 2018090
Dec 2018030
Jan 2019020
Feb 2019001
Mar 2019001
Jul 2019010
Dec 2019060
Jan 2020020
Oct 2020013
Nov 2020010
May 2021011
Sep 2021010
Oct 2022011

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 348 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 348, Issue 2
1 Feb 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Phosphoinositide 3-Kinase-δ,γ Inhibitor for Rheumatoid Arthritis
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherHighlighted Papers

Phosphoinositide 3-Kinase-δ,γ Inhibitor for Rheumatoid Arthritis

Journal of Pharmacology and Experimental Therapeutics February 1, 2014, 348 (2) 216; DOI: https://doi.org/10.1124/jpet.114.0214HIb

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherHighlighted Papers

Phosphoinositide 3-Kinase-δ,γ Inhibitor for Rheumatoid Arthritis

Journal of Pharmacology and Experimental Therapeutics February 1, 2014, 348 (2) 216; DOI: https://doi.org/10.1124/jpet.114.0214HIb
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Minimal Anticipated Biological Effect Level of Anti-CD28 Receptor Antagonist
  • Administration of Carvedilol Protects Against Doxorubicin-Induced Cardiomyopathy
  • Directly Observable Behavioral Effects of Lorcaserin in Rats
Show more Highlighted Papers

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics